Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

 
BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level.

You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines.

Q: What's mRNA’s superpower?
A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment.

Q: What's InnoRNA’s superpower?
A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment.

Q: What's HKSTP's superpower?
A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more!

Follow our page for more biotech news in Hong Kong and beyond.